In the last 12 months, insiders at 60 DEGREES PHARMACEUTICALS, INC. ($SXTP) filed 57 transactions with the SEC: 23 open-market purchases totaling $245,137 and 0 sales totaling $0. Net insider sentiment: net buying.
60 DEGREES PHARMACEUTICALS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Knight Therapeutics Inc (Not found) — 2 transactions totaling $216,182
- DOW GEOFFREY S (President and CEO) — 21 transactions totaling $170,820
- XU CHERYL (Director) — 15 transactions totaling $119,756
- MILLER TYRONE (CFO) — 7 transactions totaling $19,353
- TOOVEY STEPHEN (Director) — 3 transactions totaling $892
View all SEC Filings for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | DOW GEOFFREY S | President and CEO | P | Common Stock | 9670 | $0.80 | 59,618.0000 | 4,230,448 | 19.36% | 0.23% |
| Dec. 10, 2025 | DOW GEOFFREY S | President and CEO | P | Common Stock | 9350 | $0.95 | 46,335.0000 | 4,230,448 | 25.28% | 0.22% |
| Dec. 11, 2025 | DOW GEOFFREY S | President and CEO | P | Common Stock | 3613 | $0.92 | 49,948.0000 | 4,230,448 | 7.80% | 0.09% |
| Sept. 12, 2025 | DOW GEOFFREY S | President and CEO | A | Common Stock | 7201 | $1.39 | 44,491.0000 | 0 | 19.31% | 0.00% |
| Jan. 17, 2025 | Landon Kristen | Chief Operating Officer | A | Common Stock | 4540 | $0.00 | 4,540.0000 | 0 | 9999.99% | 0.00% |
| Sept. 26, 2024 | Landon Kristen | Chief Operating Officer | A | Stock Options (Right to Buy) | 4167 | $0.00 | 4,167.0000 | 0 | 9999.99% | 0.00% |
| June 9, 2025 | DOW GEOFFREY S | President and CEO | A | Common Stock | 4376 | $2.99 | 37,290.0000 | 0 | 13.30% | 0.00% |
| June 3, 2025 | XU CHERYL | Director | P | Common Stock | 3000 | $2.87 | 13,816.0000 | 0 | 27.74% | 0.00% |
| June 3, 2025 | XU CHERYL | Director | P | Common Stock | 2000 | $2.90 | 15,816.0000 | 0 | 14.48% | 0.00% |
| Jan. 2, 2025 | MILLER TYRONE | CFO | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | DOW GEOFFREY S | President and CEO | A | Stock Option (Right to Buy) | 525000 | $0.00 | 525,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | DOW GEOFFREY S | President and CEO | A | Common Stock | 14394 | $0.00 | 164,570.0000 | 0 | 9.58% | 0.00% |
| Jan. 17, 2025 | MILLER TYRONE | CFO | A | Common Stock | 11626 | $0.00 | 26,370.0000 | 0 | 78.85% | 0.00% |
| Dec. 13, 2024 | XU CHERYL | Director | P | Common Stock | 1500 | $1.60 | 47,578.0000 | 0 | 3.26% | 0.00% |
| Dec. 12, 2024 | XU CHERYL | Director | P | Common Stock | 2500 | $1.80 | 46,078.0000 | 0 | 5.74% | 0.00% |
| Dec. 13, 2024 | XU CHERYL | Director | P | Common Stock | 1500 | $1.58 | 49,078.0000 | 0 | 3.15% | 0.00% |
| Dec. 12, 2024 | XU CHERYL | Director | P | Common Stock | 2500 | $1.85 | 43,578.0000 | 0 | 6.09% | 0.00% |
| Dec. 13, 2024 | XU CHERYL | Director | P | Common Stock | 1500 | $1.55 | 50,578.0000 | 0 | 3.06% | 0.00% |
| Dec. 13, 2024 | XU CHERYL | Director | P | Common Stock | 1500 | $1.52 | 52,078.0000 | 0 | 2.97% | 0.00% |
| Dec. 16, 2024 | XU CHERYL | Director | P | Common Stock | 2000 | $1.45 | 54,078.0000 | 0 | 3.84% | 0.00% |
| Dec. 9, 2024 | DOW GEOFFREY S | President and CEO | P | Common Stock | 35823 | $1.27 | 150,176.0000 | 0 | 31.33% | 0.00% |
| Dec. 5, 2024 | DOW GEOFFREY S | President and CEO | P | Common Stock | 17549 | $1.11 | 93,774.0000 | 0 | 23.02% | 0.00% |
| Dec. 6, 2024 | DOW GEOFFREY S | President and CEO | P | Common Stock | 20579 | $1.20 | 114,353.0000 | 0 | 21.95% | 0.00% |
| Nov. 21, 2024 | DOW GEOFFREY S | President and CEO | P | Common Stock | 3500 | $0.91 | 76,225.0000 | 0 | 4.81% | 0.00% |
| Nov. 19, 2024 | DOW GEOFFREY S | President and CEO | P | Common Stock | 2500 | $0.90 | 71,725.0000 | 0 | 3.61% | 0.00% |
| Nov. 20, 2024 | DOW GEOFFREY S | President and CEO | P | Common Stock | 1000 | $0.92 | 72,725.0000 | 0 | 1.39% | 0.00% |
| Aug. 27, 2024 | XU CHERYL | Director | P | Common Stock | 5000 | $1.70 | 41,078.0000 | 0 | 13.86% | 0.00% |
| Dec. 31, 2023 | Allen Charles W | Director | A | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | XU CHERYL | Director | M | Restricted Stock Unit | 2000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 16, 2024 | TOOVEY STEPHEN | Director | A | Common Stock | 4000 | $0.22 | 14,000.0000 | 0 | 40.00% | 0.00% |
| May 16, 2024 | XU CHERYL | Director | M | Common Stock | 2000 | $0.22 | 228,934.0000 | 0 | 0.88% | 0.00% |
| Dec. 31, 2023 | TOOVEY STEPHEN | Director | A | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | TOOVEY STEPHEN | Director | M | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 0 | 50.00% | 0.00% |
| April 12, 2024 | MILLER TYRONE | CFO | A | Common Stock | 60000 | $0.27 | 161,928.0000 | 0 | 58.87% | 0.00% |
| May 16, 2024 | MILLER TYRONE | CFO | A | Common Stock | 15000 | $0.22 | 176,928.0000 | 0 | 9.26% | 0.00% |
| Nov. 21, 2023 | MILLER TYRONE | CFO | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| April 12, 2024 | MILLER TYRONE | CFO | M | Restricted Stock Units | 60000 | $0.00 | 15,000.0000 | 0 | 80.00% | 0.00% |
| May 16, 2024 | MILLER TYRONE | CFO | M | Restricted Stock Units | 15000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 16, 2024 | FIELD PAUL | Director | M | Common Stock | 4000 | $0.22 | 14,000.0000 | 0 | 40.00% | 0.00% |
| Dec. 31, 2023 | FIELD PAUL | Director | A | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | FIELD PAUL | Director | M | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 0 | 50.00% | 0.00% |
| April 12, 2024 | DOW GEOFFREY S | President and CEO | M | Common Stock | 68000 | $0.27 | 745,625.0000 | 0 | 10.04% | 0.00% |
| May 16, 2024 | DOW GEOFFREY S | President and CEO | M | Common Stock | 17000 | $0.22 | 762,625.0000 | 0 | 2.28% | 0.00% |
| Nov. 21, 2023 | DOW GEOFFREY S | President and CEO | A | Restricted Stock Units | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| April 12, 2024 | DOW GEOFFREY S | President and CEO | M | Restricted Stock Units | 68000 | $0.00 | 17,000.0000 | 0 | 80.00% | 0.00% |
| May 16, 2024 | DOW GEOFFREY S | President and CEO | M | Restricted Stock Units | 17000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 16, 2024 | Allen Charles W | Director | M | Common Stock | 4000 | $0.22 | 14,000.0000 | 0 | 40.00% | 0.00% |
| May 16, 2024 | Allen Charles W | Director | M | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 0 | 50.00% | 0.00% |
| July 28, 2023 | Knight Therapeutics Inc | Not found | C | Series A Non-Voting Convertible Preferred Stock | 2162 | $0.00 | 78,803.0000 | 0 | 2.67% | 0.00% |
| July 28, 2023 | Knight Therapeutics Inc | Not found | C | Common Stock, $0.0001 par value per share ("Common Shares") | 45560 | $4.75 | 1,153,897.0000 | 0 | 4.11% | 0.00% |
| Jan. 31, 2024 | XU CHERYL | Director | P | Warrant | 200000 | $0.01 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | DOW GEOFFREY S | President and CEO | P | Warrant | 25974 | $0.01 | 25,974.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | DOW GEOFFREY S | President and CEO | P | Common Stock | 25974 | $0.38 | 703,599.0000 | 0 | 3.83% | 0.00% |
| Jan. 31, 2024 | XU CHERYL | Director | P | Common Stock | 200000 | $0.38 | 424,934.0000 | 0 | 88.91% | 0.00% |
| Feb. 1, 2024 | XU CHERYL | Director | M | Common Stock | 2000 | $0.00 | 6,000.0000 | 0 | 50.00% | 0.00% |
| July 12, 2023 | DOW GEOFFREY S | President and CEO | A | Non-Qualified Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| July 12, 2023 | MILLER TYRONE | Chief Financial Officer | A | Non-Qualified Stock Options (right to buy) | 240000 | $0.00 | 240,000.0000 | 0 | 9999.99% | 0.00% |